
==== Front
MicroPubl Biol
MicroPubl Biol
microPublication Biology
2578-9430
Caltech Library

10.17912/micropub.biology.001127
New Finding
Electrophysiology Data
Drosophila
Resveratrol natural product inspired compound as a potent neuroprotectant against acute oxidative stress
Simonson Alec Conceptualization Data curation Formal analysis Investigation Writing - original draft Writing - review & editing 1
Naraine Akshay Supervision Writing - original draft Writing - review & editing Formal analysis 12
Maki Samantha Data curation Investigation Formal analysis 3
Nugent Kristina Data curation Investigation Formal analysis 3
Lepore Salvatore Conceptualization Funding acquisition Methodology Project administration Resources Supervision Writing - review & editing 3
Dawson-Scully Ken Conceptualization Formal analysis Funding acquisition Investigation Project administration Resources Supervision Writing - review & editing 14§
1 Department of Biological Sciences, Florida Atlantic University, Boca Raton, Florida, United States
2 Max Planck Florida Institute for Neuroscience, Jupiter, Florida, United States
3 Department of Chemistry and Biochemistry, Florida Atlantic University, Boca Raton, Florida, United States
4 Department of Psychology and Neuroscience, Nova Southeastern University, Fort Lauderdale, Florida, United States

§ Correspondence to: Ken Dawson-Scully ( dawsonscully@nova.edu )
The authors declare that there are no conflicts of interest present.

3 9 2024
2024
2024 10.17912/micropub.biology.00112715 1 2024
19 8 2024
22 8 2024
Copyright: © 2024 by the authors
2024
https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Resveratrol as well as natural products biosynthetically derived from it, have been shown to have protective effects against oxidative stress. However, these compounds possess poor druglike properties. At sub-nanomolar concentrations, a novel compound (RVM-6) inspired by a resveratrol natural product prolongs synaptic viability in neuromuscular junctions in D. melanogaster exposed to acute oxidative stress.

National Institutes of Health (United States) https://ror.org/01cwqze88 GM110651 Salvatore Lepore, Ken Dawson-ScullyWe wish to acknowledge the NIH (GM110651) for financial support.
==== Body
pmc Figure 1. 1a) Structure of RVM-6. 1b) RVM-6 improves synaptic viability in larvae exposed to oxidative stress. a) Structure of RVM-6 prepared in the Lepore Laboratory. b) Average times to synaptic failure are shown for w 1118 D. melanogaster 3 rd -instar larvae at different concentrations of Resveramorph 6 (RVM-6) in solution (total HL-3 n = 6; 2.25 mM H 2 O 2 n = 6; 0.1 nM RVM-6 + H 2 O 2 n = 2; 0.5 nM RVM-6 + H 2 O 2 n = 4; 1.0 nM RVM-6 + H 2 O 2 n = 6). HL-3 saline was a sham condition and positive control, and 2.25 mM H 2 O 2 was used as a negative control. Time to synaptic failure is the time in which it takes the excitatory junction potential to fall below a 1.00 mV threshold. Larvae exposed to the HL-3 sham condition averaged 199.2 minutes to reach synaptic failure. Animals exposed to 2.25 mM H 2 O 2 averaged 53.3 minutes to synaptic failure. Larvae exposed to 0.1 nM RVM-6 + H 2 O 2 averaged 75 minutes to reach synaptic failure. Larvae exposed to 0.5 nM RVM-6 + H 2 O 2 averaged 161.3 minutes to reach synaptic failure. Animals exposed to 1.0 nM RVM-6 + H 2 O 2 averaged 148.3 minutes to synaptic failure. Data are means ± the standard error of the mean (SEM). Statistical significance (p < 0.05) was designated utilizing letters where different letters indicate statistical differences, and the same letter indicates non-significance; one-way ANOVA and Holm-Sidak posthoc analysis.

Description

Drosophila melanogaster has been an effective model to study disease and oxidative stress tolerance (Armstrong et al., 2011; Mirzoyan et al., 2019; Ugur et al., 2016) . Of particular interest, the neuromuscular junction in Drosophila melanogaster utilizes glutamate as an excitatory neurotransmitter, which likens it to the human central nervous system (Ataman et al., 2006; Menon et al., 2013; Ugur et al., 2016) . One of Drosophila’s major benefits as an invertebrate model is for novel drug screening; both third instar larvae and adult flies have been well described as powerful drug discovery tools, especially for neuroprotective compounds (Millet-Boureima et al., 2021; Newman et al., 2011; Pandey & Nichols, 2011) .

Resveratrol natural products are well known for their antioxidant activities (Matsuura et al., 2015) . For example, the resveratrol dimer ε-viniferin is thought to function as a radical scavenger and its isoprenylated analogs have been demonstrated to exhibit inhibitory activity against human monoamine oxidase B (hMAO-B) leading to neuroprotective effects against ROS generation and hydrogen peroxide-induced apoptosis, albeit at micromolar-level potencies (Shang et al., 2022; Tang et al., 2019) . Nevertheless, the polyphenolic structures of resveratrol natural products often lead to rapid hepatic clearance, as was demonstrated in the case of ε-viniferin, making them poor candidates for further development as drugs (Courtois et al., 2017) . As part of a program to create more druglike compounds inspired by resveratrol natural products, we previously disclosed two novel [3.2.1] bicyclic compounds (Bollinger et al., 2019) . In this work, using drosophila larva electrophysiology recordings, we have now examined RVM-6 to further explore this compound class ( Fig. 1 a). We found that the effective threshold for RVM-6 against an oxidative stressor was 0.5 nM, and we did not detect any deleterious effects at twice that dosage ( Fig. 1 b).

Though the mechanism of RVM-6 remains an area of investigation, this compound exhibits protective effects in the sub-nanomolar range. The only other reported neuroprotective small molecule (AND-302) showed no activity at 0.5 nM, well above its reported effective dose (0.09 nM) in hippocampal cell cultures (Smith et al., 2014) . The current results offer encouraging evidence that the RVM compound system is worthy of further study as neuroprotective agents. Though some groups in the dataset are limited by sample size, the current pilot study’s findings show little variance and are in line with previously published data (Bollinger et al., 2019) . These findings serve to provide informative preliminary data that will spur future studies and inquisition about structure-activity relationships for future RVM compounds. The next step will be to examine more RVM analogs and perform a comprehensive SAR analysis to elucidate the pharmacokinetic properties of this family of compounds.

Methods

Drosophila larva electrophysiology: Individual Drosophila larvae were collected and placed on a glass-dissecting plate containing ~2 mL of Schneider's insect medium (Sigma, St. Louis, MO). Each larva was positioned with the dorsal side up on the dissecting dish using standard insect pins. Removal of the internal organs and central nervous system was achieved by making a longitudinal cut in the anteroposterior direction along the dorsal surface to expose the underlying segmental muscles and nerves. An extracellular glass suction electrode was used to stimulate segmental nerves in muscle segments. The postsynaptic excitatory junction potential (EJP) was recorded from muscle 6 with a sharp intracellular glass recording electrode filled with 3 M KAc (∼40 MΩ).

The preparation medium was replaced with HL-3 saline (1.5 mM CaCl 2 , 20 mM MgCl 2 , 5 mM KCl, 70 mM NaCl, 10 mM NaHCO 3 , 5 mM BES, 115 mM sucrose, 5 mM trehalose·2H 2 O) made fresh daily (Macleod et al., 2002; Stewart et al., 1996) . EJP recordings were viewed with an oscilloscope and digitally stored using the Scope program (AD Instruments, Colorado Springs, CO) for analysis. Evoked EJPs from repetitive stimulation (0.3-ms pulses delivered suprathreshold with a 1-Hz frequency) of both axons in larval muscle 6 were recorded in a stop-flow condition. EJP recordings were taken until synaptic transmission failure (amplitude <1 mV) occurred.

Intracellular recordings of the resting membrane potential (RMP) and input resistance were measured from larval muscle 6 with signals amplified by an IX1 intracellular preamplifier (Dagan, Minneapolis, MN). These measurements were taken as previously described (Zhang & Stewart, 2010) . Briefly, RMP measurements were taken from animals if the initial potential stabilized between −60 to −70 mV. If the membrane potential was equal to −45 mV or more depolarized, the preparation was discarded. Input resistance was measured by injecting small current pulses of 2 nA (40-ms duration at 1-Hz frequency) applied continuously. Electrode resistance was canceled prior to measuring the input resistance by adjusting the bridge balance control. Resistance was calculated using Ohm's law and only muscle fibers with an initial input resistance >5 or <40 MΩ were assayed.

Pharmacological manipulations: Drugs were dissolved directly into HL-3 saline solution and about 5 mL of solution were aliquoted into a transparent tube. Pharmacological manipulations were completed using a bath switch from HL-3 to HL-3 with drug manipulations at 4-5 minutes into trial after recording saline baseline data. HL-3 with drug manipulation remained a continuous exposure throughout the remainder of the trial. The compounds tested was RVM-6. RVM-6 is a novel compound; however, its synthesis followed a previously published procedure (Bollinger et al., 2019) . Additionally, following a previous disclosure (Smith et al. 2014) , AND-302 was synthesized.

Reagents

Strain: w 1118 (3 rd instar larvae only)

Chemicals: H 2 O 2 (CAS: 7722-84-1), RVM-6 and AND-302 (synthesized and provided by the Lepore Group)
==== Refs
Armstrong GA Xiao C Krill JL Seroude L Dawson-Scully K Robertson RM 2011 12 12 Glial Hsp70 protects K+ homeostasis in the Drosophila brain during repetitive anoxic depolarization. PLoS One 6 12 e28994 e28994 10.1371/journal.pone.0028994 22174942
Ataman B Ashley J Gorczyca D Gorczyca M Mathew D Wichmann C Sigrist SJ Budnik V 2006 5 8 Nuclear trafficking of Drosophila Frizzled-2 during synapse development requires the PDZ protein dGRIP. Proc Natl Acad Sci U S A 103 20 0027-8424 7841 7846 10.1073/pnas.0600387103 16682643
Bollinger WL St Germain EJ Maki SL Sial NK Lepore SD Dawson-Scully K 2018 11 28 Resveratrol-Inspired Bridged Bicyclic Compounds: A New Compound Class for the Protection of Synaptic Function from Acute Oxidative Stress. ACS Chem Neurosci 10 1 221 225 10.1021/acschemneuro.8b00577 30462482
Courtois A Jourdes M Dupin A Lapèze C Renouf E Biais B Teissedre PL Mérillon JM Richard T Krisa S 2017 5 3 In Vitro Glucuronidation and Sulfation of ε-Viniferin, a Resveratrol Dimer, in Humans and Rats. Molecules 22 5 10.3390/molecules22050733 28467376
Macleod GT Hegström-Wojtowicz M Charlton MP Atwood HL 2002 11 1 Fast calcium signals in Drosophila motor neuron terminals. J Neurophysiol 88 5 0022-3077 2659 2663 10.1152/jn.00515.2002 12424301
Matsuura BS Keylor MH Li B Lin Y Allison S Pratt DA Stephenson CR 2015 2 4 A scalable biomimetic synthesis of resveratrol dimers and systematic evaluation of their antioxidant activities. Angew Chem Int Ed Engl 54 12 1433-7851 3754 3757 10.1002/anie.201409773 25650836
Menon KP Carrillo RA Zinn K 2013 2 5 Development and plasticity of the Drosophila larval neuromuscular junction. Wiley Interdiscip Rev Dev Biol 2 5 1759-7684 647 670 10.1002/wdev.108 24014452
Millet-Boureima C Selber-Hnatiw S Gamberi C 2020 6 18 Drug discovery and chemical probing in Drosophila. Genome 64 2 0831-2796 147 159 10.1139/gen-2020-0037 32551911
Mirzoyan Z Sollazzo M Allocca M Valenza AM Grifoni D Bellosta P 2019 3 1 Drosophila melanogaster: A Model Organism to Study Cancer. Front Genet 10 1664-8021 51 51 10.3389/fgene.2019.00051 30881374
Newman T Sinadinos C Johnston A Sealey M Mudher A 2011 2 1 Using Drosophila models of neurodegenerative diseases for drug discovery. Expert Opin Drug Discov 6 2 1746-0441 129 140 10.1517/17460441.2011.549124 22647132
Pandey UB Nichols CD 2011 3 17 Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol Rev 63 2 0031-6997 411 436 10.1124/pr.110.003293 21415126
Shang Yaxuan Li Xiangzhou Li Zhaoshuang Shen Liqun Zhou Jun Hu Runfeng Chen Kai 2022 7 1 Mechanistic study on the radical scavenging activity of viniferins Journal of Molecular Structure 1260 0022-2860 132830 132830 10.1016/j.molstruc.2022.132830
Smith GR Brenneman DE Zhang Y Du Y Reitz AB 2013 11 26 Small-molecule anticonvulsant agents with potent in vitro neuroprotection and favorable drug-like properties. J Mol Neurosci 52 3 0895-8696 446 458 10.1007/s12031-013-0180-8 24277343
Stewart BA Schuster CM Goodman CS Atwood HL 1996 6 15 Homeostasis of synaptic transmission in Drosophila with genetically altered nerve terminal morphology. J Neurosci 16 12 0270-6474 3877 3886 10.1523/JNEUROSCI.16-12-03877.1996 8656281
Tang YW Shi CJ Yang HL Cai P Liu QH Yang XL Kong LY Wang XB 2018 11 26 Synthesis and evaluation of isoprenylation-resveratrol dimer derivatives against Alzheimer's disease. Eur J Med Chem 163 0223-5234 307 319 10.1016/j.ejmech.2018.11.040 30529634
Ugur B Chen K Bellen HJ 2016 3 1 Drosophila tools and assays for the study of human diseases. Dis Model Mech 9 3 1754-8403 235 244 10.1242/dmm.023762 26935102
Zhang B Stewart B 2010 9 1 Electrophysiological recording from Drosophila larval body-wall muscles. Cold Spring Harb Protoc 2010 9 pdb.prot5487 pdb.prot5487 10.1101/pdb.prot5487 20810634
